[1] Hall J E.Historical perspective of the renine-angiotensin system[J]. Mol Biotechnol,2003,24:27-39.
[2] 钱桐荪.肾素-血管紧张素系统的新概念(上)[J]. 中国中西医结合肾病杂志,2007,8:311-313.
[3] 贾坚,门琛. 肾素-血管紧张素-醛固酮系统基因多态性与血管紧张受体阻滞剂降压疗效相关行的研究进展[J].心血管病学进展,2012,33:81-84.
[4] 李立人,戴耀宗,刘久敏.测定醛固酮浓度/肾素活性(SAC/PRA)值在原发性醛固酮增多症中的临床意义[J].放射免疫学杂志,2003,16:71-72.
[5] 王丽萍.肾素-血管紧张素-醛固酮系统在糖尿病及其血管合并症中的作用[J].实用医学杂志,2006,22:608-609.
[6] 田嵩.高血压三项的实验室检查及临床分析[J].中外医疗,2010,11:172.
[7] Drayer J I,Benraad T J.The reliability of the measurement of plasma renin activity by Radioimmunoassay[J]. Clin Chim Aeta, 1975, 61:309-324.
[8] Sealey J E.Plasma rennin ativity and plasma prorenin assays[J]. Clin Chen,1991,37:1811-1819.
[9] Morganti A, Pelizzola D, Mantero F, et al. Immunoradiometric versus enzymatic renin assay: results of the Italian Multicenter Comparative Study. Italian Multiceuter Study for Standardization of Renin Measurement[J]. J Hgperters, 1995,13:19-26.
[10] Sealey J E, Trenkwalder P, Gahnem F, et al. Plasma rennin methodology: inadequate sensitivity and accuracy of direct renin assay for dinical applications compared with the traditional enzymatic plasma renin activity assay[J]. J Hypertens, 1995,13:27-30.
[11] de Bruin R A. Validation of a New Automated Renin Assay[J]. Clinical Chemistry,2004, 50(11): 2111-2116.
[12] Qu X, Deo S K, Dikici E. Bioluminescence immunoassay for angiotensin II using aequorin as a label[J]. Analytical Biochemistry, 2007, 371(2):154-161.
[13] Klickstein LB, Wintroub BU. Separation of angiotensins and assay of angiotensin-generating enzymes by high-performance liquid chromatography[J]. Anal Biochem, 1982,120:146-150.
[14] Miyazaki T, Kai M, Ohkura Y. Determination of renin activity in human plasma bycolumn-switching high performance liquid chromatography with fluorescence deletion[J].J Chromatogr, 1989, 490:43-51.
[15] Nakamura-Imajo N., Satomura S., Matsuura S., et a1. Renin assay using a fluorogenic subslmte and high performance liquid chromatography[J].Clin Chim Acta, 1992, 211: 47-57.
[16] Fredline V F, Kovacs E M, Taylor P J, et a1.Measurement of plasma renin aetivity withuse of HPL-Celectrospmy-tandem nlagg spectrometry[J].Clin Chem, 1999,45: 659-664.
[17] Kajiro T, Nakajima Y, Fukushima T, et a1.A method to evaluate the rennin-angiotensin system in rat renal cortex using a microdialysis techniquecombined with HPLC-fluorescence detection[J].Anal Chem, 2002, 74: 4519-4525.
[18] Ménard J, Bews J, Heusser C.ISA for the measurement of plasma renin in humans and primates[J].J Hypertens Suppl, 1984, 2: S275-278.
[19] Yasunaga F, Kawano A, Morikawa N, et a1. Enzymeimmunoassay of angiotensin II in human plasma[J].Chem Pharm Bull(Tokyo), 1992, 40:792-794.
[20] Volland H, Pradelles P, Ronco P, et a1. A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma[J], J Immunological Methods, 1999, 228(1-2): 37-47.
[21] Lacher N A, Garrison K E, Lunte S M. Separation and detection ofangiotensin peptides by Cu(II) complexation and capillaryelectrophoresis with UV and electrochemical detection[J].Electrophoresis, 2002, 23:1577-1584.
